Green Tea

Green Tea

Paradise4.6 (232 ratings)
Format:Capsule Quantity: 120 Capsule(s) · 120 servings
Goals
$13.49 $0.11 per serving

Product analysis

48 out of 100

Green Tea supplies compounds with antioxidant activity. Its active-compound amounts are unclear, making it difficult to compare with the preparations used in research.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The detailed tea form is not disclosed, leaving its quality uncertain. The tea amount does not identify the amounts of active compounds.

Ingredient Transparency63

The amount of green tea material is disclosed. Its detailed form is missing, and that amount does not establish caffeine, theanine or EGCG exposure.

Value For Money40

The active EGCG amount is unknown, preventing a useful cost comparison for that compound. The value of the tea serving remains uncertain.

Customer Satisfaction72

Customer ratings are positive. The smaller review pool leaves more uncertainty, and ratings do not prove effectiveness or safety.

Product Focus70

The ingredient has antioxidant relevance across several proposed aims. The evidence does not establish routine cognitive improvements, inflammation relief or longer life from this declaration.

Format
Capsule
Container
120 Capsule(s)
Per serving
$0.11
Customer rating
4.6 · 232 ratings
Report analysis

Goals

Inflammation
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Green Tea · 250 mg

Green tea has antioxidant relevance, but the supplied metabolic-syndrome trial found most inflammatory markers unchanged. Its limited serum-amyloid finding does not establish routine clinical benefit or a preparation-matched generic EGCG dose. The serving contains 250 mg of green tea material; extract mass and active EGCG mass are not interchangeable.

How this product is rated for Inflammation

Ingredient fit75

The declared active ingredients are relatively focused on relevant roles, though their other uses also affect the finding. Amounts provide a limited match to the saved comparison ranges; unresolved quantities cannot establish a contribution.
Goal fit
The declared active ingredients are relatively focused on relevant roles, though their other uses also affect the finding.
Dose adequacy
Amounts provide a limited match to the saved comparison ranges; unresolved quantities cannot establish a contribution.

Pathways13

The strongest saved finding concerns oxidative stress, which does not itself establish clinical inflammation relief. None of the assessed routes reaches the saved coverage threshold.
Depth
The strongest saved finding concerns oxidative stress, which does not itself establish clinical inflammation relief.
Breadth
None of the assessed routes reaches the saved coverage threshold.

Evidence73

Green Tea leads the saved evidence finding, but the scientific context limits claims of routine clinical benefit. Recognized preparation matching does not remove those limitations.
Evidence strength
Green Tea leads the saved evidence finding, but the scientific context limits claims of routine clinical benefit.
Studied preparation
The counted preparations match those recognized in the saved findings; the supplied population and outcome limitations still apply.

Formulation logic100

Counted ingredients meet the saved amount threshold and partner requirements, with no configured conflict identified. These findings do not establish synergy or comprehensive safety.
Partner coverage
The counted ingredients work independently or have their required partner in the saved findings.
Conflicts
No configured ingredient conflict was identified; this does not assess every possible interaction.
Effective doses
All counted ingredients clear the saved amount threshold, a comparison rule rather than a proven effective dose.
Study evidence
Longevity
Impact
High effect
B Ingredient FitD PathwaysB+ EvidenceA+ Formulation Logic
Green Tea · 250 mg

Green tea supplies compounds associated with antioxidant activity. The supplied information does not establish preservation of age-related function or longer life from this extract, and beverage, extract and active EGCG amounts cannot be treated as equivalent.

How this product is rated for Longevity

Ingredient fit80

The ingredient selection and amounts provide a partial picture of how this formula relates to age-related outcomes.
Goal fit
The relevant ingredients make up most of the formula, although it is also linked to other goals.
Dose adequacy
The included amounts only partly meet the saved amount references; unknown amounts cannot establish a contribution.

Pathways45

The represented mechanisms describe ingredient roles; they do not themselves establish preservation of function or longer life.
Depth
The strongest represented mechanism is antioxidant defence, a mechanistic connection rather than proof of slower aging.
Breadth
Coverage is concentrated in one mechanism rather than spread across several aging-related functions.

Evidence82

The human findings remain specific to the ingredient, preparation and outcome described.
Evidence strength
Green Tea supplies the strongest included evidence contribution, while its specific human-outcome limitations still apply.
Studied preparation
The saved findings recognize the included preparations; this does not expand their supported outcomes or populations.

Formulation logic100

Partner requirements, identified conflicts and minimum amounts are considered separately, without assuming combination benefits.
Partner coverage
The included contributors can act independently or have the required partner; this does not establish added benefit from combining them.
Conflicts
No matching ingredient conflict was identified in the supplied assessment.
Effective doses
All included contributors meet the saved minimum amount threshold, which is not a proven minimum effective human dose.
Study evidence
Green Tea Supportive 9 studies
Cognitive Support
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Green Tea · 250 mg

Green tea can contain caffeine and theanine, but the declared 250 mg tea amount establishes neither compound's exposure. Antioxidant activity alone does not demonstrate better memory or attention. The saved comparison assigns partial amount recognition and an oxidative-protection contribution, but the supplied scientific context does not establish a routine cognitive benefit for this declaration.

How this product is rated for Cognitive Support

Ingredient fit75

Green tea is the single relevant ingredient in the saved findings.
Goal fit
Green tea is the single relevant ingredient in the saved findings.
Dose adequacy
The tea amount receives partial recognition; caffeine and theanine quantities cannot be inferred.

Pathways19

Oxidative and inflammatory protection has partial saved coverage.
Depth
Oxidative and inflammatory protection has partial saved coverage.
Breadth
No pathway reaches the saved breadth threshold.

Evidence81

The supplied context does not establish routine cognitive benefit from tea extract mass alone.
Evidence strength
The supplied context does not establish routine cognitive benefit from tea extract mass alone.
Studied preparation
The saved findings recognize the included preparations; this does not remove the ingredient-specific limits on cognitive benefit.

Formulation logic100

The included ingredients require no missing partner, and no configured conflict was found.
Partner coverage
No required partner is missing for the included ingredients; this does not imply added benefit from combining them.
Conflicts
No configured ingredient conflict was found in the supplied facts.
Effective doses
All included ingredients meet the saved minimum amount threshold; that threshold is not proof of cognitive benefit.
Study evidence
Green Tea Supportive 32 studies

Ingredients

IngredientAmount per servingScore
Green Tea leaf extract
250 mg 8
Gluten Free Adults 18–50 Vegan No Allergies Vegetarian
Report overview
Green Tea · 250 mg OverallScore8
F Composition And Label DisclosureF Composition And Label DisclosureF Commercial Price And Usability
Each serving contains 250 mg of green tea leaf extract. Its EGCG content is not established in the saved facts, so the amount cannot be compared on that basis.
How this ingredient is rated

Composition and Label Disclosure20

The extract is identified, but its EGCG concentration is unknown.
Declared Green Tea Marker Concentration
The serving contains 250 mg of green tea leaf extract; no marker concentration is recorded.

Composition and Label Disclosure0

The whole-product caffeine amount is unknown from the saved facts.
Whole-Product Caffeine Disclosure
No caffeine information is recorded in the saved facts, so the whole-product amount is unknown.

Commercial Price and Usability0

The EGCG amount is unavailable for a cost comparison.
Cost per 200 mg Declared EGCG
An EGCG price comparison is unavailable because the saved facts do not establish the EGCG amount.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
    de la Torre R; de Sola S; Hernandez G; Farré M; Pujol J; Rodriguez J; Espadaler JM; Langohr K; Cuenca-Royo A; Principe A; Xicota L; Janel N; Catuara-Solarz S; Sanchez-Benavides G; Bléhaut H; Dueñas-Espín I; Del Hoyo L; Benejam B; Blanco-Hinojo L; Videla S; Fitó M; Delabar JM; Dierssen M; TESDAD study group · The Lancet. Neurology · 2017
    Randomized trial87 participantsCognitive Support forGreen Tea
  2. Association between tea consumption and risk of cognitive disorders: A dose-response meta-analysis of observational studies.
    Liu X; Du X; Han G; Gao W · Oncotarget · 2018
    Meta-analysis48,435 participants17 studies pooledCognitive Support forGreen Tea
  3. Investigating the Impact of Tea Consumption on Cognitive Function and Exploring Tea-Genetic Interactions in Older Adults Aged 65-105 Years: Findings from the 2002-2018 CLHLS Data.
    Yu L; Yang M; Ye KX; Li C; Zou M; Wang J; Yuan X; Zheng D; Sun C; Zhang Y; Feng Q; Maier AB; Sun L; Feng L; Wang Y; Chen H; Zeng Y · The journal of prevention of Alzheimer's disease · 2024
    Cohort study76,270 participantsCognitive Support forGreen Tea
  4. Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline.
    Noguchi-Shinohara M; Yuki S; Dohmoto C; Ikeda Y; Samuraki M; Iwasa K; Yokogawa M; Asai K; Komai K; Nakamura H; Yamada M · PloS one · 2014
    Cohort study490 participantsCognitive Support forGreen Tea
  5. Green Tea Consumption and the Risk of Incident Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study.
    Tomata Y; Sugiyama K; Kaiho Y; Honkura K; Watanabe T; Zhang S; Sugawara Y; Tsuji I · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2018
    Cohort study13,645 participantsCognitive Support forGreen Tea
  6. The effects of green tea on acne vulgaris: A systematic review and meta-analysis of randomized clinical trials.
    Kim S; Park TH; Kim WI; Park S; Kim JH; Cho MK · Phytotherapy research : PTR · 2021
    Meta-analysis247 participants5 studies pooledInflammation forGreen Tea
  7. Green Tea Catechin Association with Ultraviolet Radiation-Induced Erythema: A Systematic Review and Meta-Analysis.
    Kapoor MP; Sugita M; Fukuzawa Y; Timm D; Ozeki M; Okubo T · Molecules (Basel, Switzerland) · 2021
    Meta-analysis100 participants6 studies pooledInflammation forGreen Tea
  8. Efficacy of (-)-epigallocatechin gallate delivered by a new-type scaler tip during scaling and root planing on chronic periodontitis: a split-mouth, randomized clinical trial.
    Wang Y; Zeng J; Yuan Q; Luan Q · BMC oral health · 2021
    Randomized trial20 participantsInflammation forGreen Tea
  9. Camellia Sinensis Mouthwashes in Oral Care: a Systematic Review.
    Tafazoli A; Tafazoli Moghadam E · Journal of dentistry (Shiraz, Iran) · 2020
    Systematic review69 studies pooledInflammation forGreen Tea
  10. Skin photoprotection by green tea: antioxidant and immunomodulatory effects.
    Katiyar SK · Current drug targets. Immune, endocrine and metabolic disorders · 2004
    Narrative reviewInflammation forGreen Tea
  11. Green tea and coffee intake and risk of cognitive decline in older adults: the National Institute for Longevity Sciences, Longitudinal Study of Aging.
    Shirai Y; Kuriki K; Otsuka R; Kato Y; Nishita Y; Tange C; Tomida M; Imai T; Ando F; Shimokata H · Public health nutrition · 2021
    Cohort study1,305 participantsLongevity forGreen Tea
  12. Associations of green tea, coffee, and soft drink consumption with longitudinal changes in leukocyte telomere length.
    Sohn I; Shin C; Baik I · Scientific reports · 2023
    Cohort study1,952 participantsLongevity forGreen Tea
  13. Can teatime increase one's lifetime?
    Nakachi K; Eguchi H; Imai K · Ageing research reviews · 2003
    Cohort studyLongevity forGreen Tea
  14. Influences of tea consumption on self-rated health and life satisfaction among older adults: Evidence from the CLHLS.
    Zou M; Sun C; Yang M; Li C; Wang S; Zheng D; Wang J; Yu L; Sun L; Wang Y; Chen H; Zeng Y · PsyCh journal · 2025
    Cohort study78,345 participantsLongevity forGreen Tea
  15. Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin.
    Chiu AE; Chan JL; Kern DG; Kohler S; Rehmus WE; Kimball AB · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2005
    Randomized trial40 participantsLongevity forGreen Tea